• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在心脏选择性负荷下缺血性心脏病的发病机制治疗可能性]

[The possibilities for the pathogenetic therapy of ischemic heart disease under cardioselective loading].

作者信息

Ardashev V N, Smirnov A V, Ryndin A A, Shcherbak Iu A

出版信息

Voen Med Zh. 1994 Jul(7):29-31, 79.

PMID:7810109
Abstract

The authors describe the method for the treatment of ischemic heart disease (IHD) with stenocardia at rest or tension which is refractory for basic therapy. This method consists of intravenous injection of phosphobion on the background of transesophageal electrocardiostimulation. Anti-ischemic and positive hemodynamic effects were marked during application of this method in 16 patients with IHD. On the contrary the traditional method based on administration of adesinotriphosphorous acid didn't give positive clinical results.

摘要

作者描述了一种治疗缺血性心脏病(IHD)伴静息或劳力性心绞痛且基础治疗无效的方法。该方法是在经食管心电刺激的背景下静脉注射复合维生素B。在16例缺血性心脏病患者应用此方法期间,观察到了抗缺血和积极的血流动力学效应。相反,基于三磷酸腺苷给药的传统方法未取得积极的临床效果。

相似文献

1
[The possibilities for the pathogenetic therapy of ischemic heart disease under cardioselective loading].[在心脏选择性负荷下缺血性心脏病的发病机制治疗可能性]
Voen Med Zh. 1994 Jul(7):29-31, 79.
2
[Therapeutic effect of intravascular phosphobion during transesophageal electric cardiostimulation in patients with ischemic heart disease].[血管内磷生素在缺血性心脏病患者经食管心脏电刺激中的治疗作用]
Klin Med (Mosk). 1993;71(2):21-4.
3
[Transesophageal electrocardiostimulation in the diagnosis of ischemic heart disease in elderly patients].[经食管心电刺激在老年缺血性心脏病诊断中的应用]
Ter Arkh. 1992;64(10):76-9.
4
[A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].[对接受抗心绞痛药物治疗的缺血性心脏病患者心脏活动指标的数学分析]
Eksp Klin Farmakol. 1995 Jan-Feb;58(1):31-3.
5
[The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].[氦氖激光照射对缺血性心脏病患者心肌和甲状腺功能的影响]
Vopr Kurortol Fizioter Lech Fiz Kult. 1997 Sep-Oct(5):7-9.
6
[The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].新型心脏保护剂硫代三唑啉在老年患者缺血性心脏病治疗中的应用
Eksp Klin Farmakol. 1996 Jan-Feb;59(1):21-3.
7
[The cardiohemodynamic characteristics of the action of obzidan in patients with an artificial pacemaker and ischemic heart disease with different types of blood circulation].[奥布西丹对植入人工起搏器且患有不同血液循环类型缺血性心脏病患者作用的心脏血液动力学特征]
Eksp Klin Farmakol. 1996 Jul-Aug;59(4):21-4.
8
[The role of metabolic correction in the combined therapy of middle-aged and elderly patients with ischemic heart disease].
Lik Sprava. 1996 Oct-Dec(10-12):114-6.
9
[The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].[普索洛尔(一种具有α-肾上腺素能阻断特性的新型β-肾上腺素能阻滞剂)单次用于劳力性稳定型心绞痛患者的疗效]
Eksp Klin Farmakol. 1994 May-Jun;57(3):47-50.
10
[The correlations of lipid peroxidation, antioxidant protection and microrheological disorders in the development of IHD].[脂质过氧化、抗氧化保护与缺血性心脏病发展过程中的微观流变学紊乱之间的相关性]
Ter Arkh. 1996;68(9):37-40.